Life Sciences Ontario is pleased to announce the recipients of its 2024 LSO Awards, recognizing outstanding individuals and companies contributing to the success of...
Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in USA, are pleased to announce...
ConcertAI and Caris Life Sciences (Caris) announced a multi-year partnership to support AbbVie's precision medicine-driven research and development efforts, and clinical trial optimization in...
Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, announced the release of a groundbreaking product developed from Paige’s Pathology...
insitro, a machine learning-powered drug discovery and development company, announced the appointment of S. Michael Rothenberg, M.D., Ph.D., as chief medical officer. In this...
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, announced a research collaboration with NVIDIA to accelerate the...
Deep 6 AI, a leading AI-powered precision research platform for healthcare organizations and life sciences companies, announced its partnership with Graticule, an on-demand, advanced real-world...
Isomorphic Labs, a digital biology company with a mission to redefine drug discovery using the power of artificial intelligence, announced that it has entered...
Quris-AI, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, announced the addition of Michel Vounatsos, former CEO of Biogen, to its Board of Directors,...
Chicago-based Evozyne announced Marc Yoskowitz as CEO of the generative AI-driven biotech.
Yoskowitz, most recently chief strategy officer and executive vice president, life sciences, at...